Show simple item record

CD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?

dc.contributor.authorAgahozo, MCen_US
dc.contributor.authorPeferoen, Len_US
dc.contributor.authorBaker, Den_US
dc.contributor.authorAmor, Sen_US
dc.date.accessioned2016-09-15T09:29:31Z
dc.date.available2016-07-19en_US
dc.date.issued2016-09en_US
dc.date.submitted2016-08-25T13:57:34.349Z
dc.identifier.issn2211-0348en_US
dc.identifier.urihttp://qmro.qmul.ac.uk/xmlui/handle/123456789/15382
dc.format.extent110 - 117en_US
dc.language.isoenen_US
dc.relation.ispartofMULTIPLE SCLEROSIS AND RELATED DISORDERSen_US
dc.rights© 2016. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectMultiple sclerosisen_US
dc.subjectAnimal modelsen_US
dc.subjectExperimental autoimmune encephalomyelitisen_US
dc.subjectTherapeuticsen_US
dc.subjectB cellsen_US
dc.subjectCD20en_US
dc.subjectEpstein-Barr virusen_US
dc.titleCD20 therapies in multiple sclerosis and experimental autoimmune encephalomyelitis - Targeting T or B cells?en_US
dc.typeArticle
dc.rights.holder© 2016 Elsevier B.V. All rights reserved.
dc.identifier.doi10.1016/j.msard.2016.07.011en_US
pubs.author-urlhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000384862000023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume9en_US


Files in this item

Thumbnail
Name:
Baker CD20 Therapies in Multiple ...
Size:
473.3Kb
Format:
application/
Description:
Accepted version
View/Open
Thumbnail
Name:
Baker CD20 Therapies in Multiple ...
Size:
1.937Mb
Format:
application/
Description:
Accepted version (Figures)
View/Open

This item appears in the following Collection(s)

Show simple item record